Agreements reached under this partnership
Business Alliances- 1
U.S. sales partnership for Bondlido
- 2
Discussions on the detailed terms of the sales license agreement
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
Sales volume expected over the next several years is projected to exceed the assumptions made when the term sheet was signed
The impact on the Company's results for the fiscal year ending December 2026 is expected to be minor
| Item | Details |
|---|---|
| Name of alliance partner | Terrain Pharmaceuticals |
| Alliance partner's business activities | A U.S. specialty pharmaceutical company with more than 10 years of experience developing and marketing topical pain relievers. Through a nationwide distribution network that includes independent retail pharmacies, specialty pharmacies and healthcare providers, it markets prescription and over-the-counter topical patches and semisolid formulations, including products based on lidocaine and NSAIDs. |
| Alliance partner's location | Reno, Nevada, U.S. |
| Type of alliance | Business Alliances |
| Details of the alliance | U.S. sales partnership for Bondlido, Discussions on the detailed terms of the sales license agreement |
| Numerical targets under the alliance | Sales volume expected over the next several years is projected to exceed the assumptions made when the term sheet was signed |
| Contract Date | May 2026 (legally binding term sheet) |
| Impact on Business Performance | The impact on the Company's results for the fiscal year ending December 2026 is expected to be minor |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The sales volume expected over the next several years is now projected to exceed the assumptions made when the term sheet was signed, and additional time is required to review the sales strategy, supply plan and contractual terms.